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Abstract
Background:Preeclampsia is considered as a serious life-threatening condition that could affect
both maternal and fetal outcome. Many studies have examined the association of nutritional
factors with the incidence of preeclampsia. However, little is known about the possible role of
vitamin D in the development of preeclampsia among the Iranian population.
Objective: The aim of the present study was to evaluate the association between vitamin D
status and preeclampsia.
Materials and Methods: A total of 120 pregnant women who were referred to Kamali and
Alborz General Hospital located in the Karaj City were enrolled in this study and categorized
into preeclamptic and control groups (n = 60/each). The clinical details of patients such as
demographic characteristics and laboratory findings were obtained from the patients. The
serum levels of vitamin D, calcium, phosphorus, and parathormone were also measured.
Multivariate logistic regression analysis was used to assess for independent predictors of
preeclampsia.
Results: The mean age among pregnant women with preeclampsia and control group
were 31.48 ± 5.25 and 29.01 ± 5.28, respectively. The mean body mass index among
the preeclamptic group was 27.92 ± 4.98, which was significantly higher compared to the
control group (p < 0.001). The serum vitamin D levels were significantly lower in women with
preeclampsia compared to the control subjects (p = 0.007). Moreover, no correlation between
vitamin D deficiency and predisposing factors of preeclampsia was observed after adjusting for
confounding factors.
Conclusion: Our study revealed that serum vitamin D level is significantly lower in among the
pregnant women diagnosed with preeclampsia compared to the healthy subjects. However,
no correlation was observed between the vitamin D status and the risk of preeclampsia
development.
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1. Introduction
Preeclampsia is a pregnancy disorder defined
as elevated blood pressure and presence of pro-
teinuria after the 20th wk of gestation that could
affect various organ system in the body (1). This con-
dition is estimated to occur in 2-8% of pregnancies
and has been closely related to substantial mater-
nal and fetal/neonatal morbidity and mortality (1, 2).
Despite the increasing knowledge of its pathology
and clinical manifestations, its exact underlying
etiology remains largely unknown. However, sev-
eral causative mechanisms have been identified to
contribute to the development and progression of
preeclampsia including placental origin, immuno-
logic origin, and genetic predisposition factors (3,
4). Moreover, the main predisposing risk factors for
developing preeclampsia include metabolic syn-
drome profile, endothelial dysfunction, oxidative
stress, and increased inflammatory markers have
also been suggested (5-7).
Vitamin D is a group of steroid hormones,
derived from both diet and sunlight; it also plays
an important role in innate immunity and many
aspects of cellular functions (8). Vitamin D has
been associated with a variety of pregnancy evo-
lution such as gene regulation and expression
in early placental development during pregnancy,
fetomaternal immunological tolerance, and anti-
inflammatory responses (9, 10). Vitamin D defi-
ciency has recently been gaining attention in
regards to its implication in the pathophysiology
associated with preeclampsia (11). Previous studies
have indicated that vitamin D improves endothelial
function via regulating gene expression associated
with placental invasion, and angiogenesis during
normal implantation (12). Moreover, in-vitro and
animal models have shown that vitamin D has a
negative regulatory effect on the renin-angiotensin
system by suppressing renin gene expression (13,
14). Although these findings have suggested that
serum vitamin D levels are linked to blood pressure,
yet it is largely unclear if vitamin D measurement
should become part of routine hypertension pre-
vention.
Since limited data exist regarding the associ-
ation between serum vitamin D status and the
presence of preeclampsia among Iranian women,
the present study was conducted to compare
vitamin D levels in two groups of pregnant women
with preeclampsia and healthy subjects.
2. Materials and Methods
2.1. Patients
The present prospective case-control study was
conducted at two educational hospitals (Kamali
and Alborz General Hospital) located in Karaj City
from January 2016 to March 2017. A total of 60
pregnant women diagnosed with preeclampsia
were assessed for eligibility based on the selec-
tion criteria. Patients were included if they were
nulliparous preeclamptic women and aged 18-45
yr. Preeclampsia and proteinuria were defined
according to the American College of Obstetricians
and Gynecologists guidelines (15). Briefly, patients
were considered to have preeclampsia if systolic
blood pressure ≥ 140 mmHg and/or a diastolic
pressure ≥ 90 mmHg. Proteinuria was defined as
≥ 300 mg/24 hr or 30 mg/dl (1+ dipstick) in at least
one random urine sample after 20 wk of gestation.
Patients with preexisting medical conditions such
as the previous history of hypertension, diabetes,
renal or liver failure, thyroid disease, malabsorp-
tion, multiple pregnancies, and history of intake
of medications that may interfere with vitamin
D or calcium metabolism such as anti-epileptics,
anti-inflammatory agents, or antiretroviral drugs in
the last six months were excluded. The control
group consisted of 60 healthy nulliparous pregnant
women who were age- and sex-matched with
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no history of major morbidity. The clinical details
of patients such as demographic characteristics
and laboratory findings were obtained from the
patients.
2.2. Measurements
Blood samples were collected to evaluate vita-
min D, serum calcium, and alkaline phosphatase
levels. Vitamin D was measured using the ELISA
method (Immune Diagnostic Systems, UK). A blood
level of vitamin D above 30 ng/ml was considered
sufficient, while values between 20 and 30 ng/ml
as insufficient, and values below 20 ng/ml as
deficient.
2.3. Ethical consideration
Written informed consent was gathered from
the subjects prior to sampling. The study was
approved by the Ethics Committee of Shahid
Sadoughi University of Medical Sciences (Code:
IR.SSU.SPH.REC.1935.130). The process of this
study was performed in accordance with the Decla-
ration of Helsinki and other applicable guidelines,
laws, and regulations (16).
2.4. Statistical analysis
Normally distributed data are represented as
means and standard deviations. Non-normally dis-
tributed data are shown as medians with interquar-
tile ranges. Kolmogorov-Smirnov test was used to
evaluate the normal distribution of the quantita-
tive variables. Statistical comparisons were per-
formed using independent t-test (for quantitative
variables) and the chi-square test (for qualitative
variables). Multivariate logistic regression analysis
was used to assess for independent predictors
of preeclampsia. In addition, correlation analysis
was used to evaluate the association between
different continuous variables of the study. P <
0.05 was considered significant in all tests. All data
were analyzed using SPSS 20.0 (Statistical Pack-
age for the Social Sciences, SPSS Inc.; Chicago,
IL).
3. Results
The demographic characteristics of 60 women
with preeclampsia and 60 control patients were
summarized in Table I. The mean age at the time of
study among pregnant women with preeclampsia
and control group was 31.48 ± 5.25 and 29.01 ±
5.28, respectively. Women with preeclampsia had
a significantly lower gestational age compared to
the control group (p = 0.003). Among women with
preeclampsia, 66.7% of subjects were found to be
obese which was significantly higher than the con-
trol participants (p<0.001). Positive family history of
preeclampsia was present in 3 (5%) preeclamptic
women. The mean BMI among the preeclamptic
group was 27.92 ± 4.98, which was significantly
higher compared to the control group (p < 0.001).
The daily vitamin D supplementation of 1,000 IU
was used among 12 patients with preeclampsia.
The supplement usage such as calcium, Omega-
3, iron, and vitamin D were significantly higher
in women with preeclampsia compared to the
control group. Moreover, there was no significant
difference in regards to vitamin D deficiency across
groups (p = 0.137). The serum vitamin D levels were
significantly lower in women with preeclampsia
compared to the control subjects (p = 0.007) (Table
II).
The mean serum vitamin D levels were 6.88
± 9.46 ng/ml, while in the control group, they
were 13.41 ± 8.05 ng/ml. However, there was no
significant difference in regards to serum phos-
phorus, calcium, and PTH levels between the
two groups (Figure 1). The daily average dietary
energy and nutrient intakes are summarized in
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Table III. The nutritional assessment revealed
that women with preeclampsia had lower energy
intake compared to the control subjects; how-
ever, this difference did not reach the statically
significance (p = 0.688). Protein and fat intake
were lower in the preeclamptic women than
the control pregnant subjects, but the difference
was not statistically significant (p > 0.05). After
adjusting for all known potential confounding fac-
tors, multiple logistic regression was performed
in order to determine the association between
vitamin D deficiency and factors associated with
preeclampsia development. The results suggest
that there was no correlation between vitamin D
deficiency and predisposing factors of preeclamp-
sia (Table IV).
Table I. Comparison of demographic characteristics between patients with preeclampsia and control group
Parameters Preeclampsia Control P-value
Age (yr)* 31.48 ± 5.25 29.01 ± 5.28 0.017𝑎
Gestational age (wk)* 227.86 ± 30.47 241.28 ± 33.37 0.003𝑎
Height (cm)* 161.93 ± 5.94 162.31 ± 6.20 0.95𝑎
BMI (kg/m2)* 27.92 ± 4.98 24.33 ± 3.87 < 0.001𝑎
Weight before pregnancy (kg)* 73.26 ± 13.97 66.01 ± 10.30 < 0.001𝑎
Weight at first trimester (kg)* 84.11 ± 13.92 76.23 ± 9.72 < 0.001𝑎
Systolic blood pressure (mmHg)* 146.78 ± 7.84 105.51 ± 10.32 < 0.001𝑎
Diastolic blood pressure (mmHg)* 55.60 ± 40.19 86.33 ± 82.21 0.268𝑎
Educational level** 0.002𝑏
Primary school 25 (41.6) 7 (11.6)
Secondary school 27 (45) 35 (58.3)
College 8 (13.3) 18 (30)
History of miscarriage** 23 (38.3) 9 (15.1) 0.004𝑏
History of preeclampsia** 3 (5) 0 (0) 0.244𝑏
Family history of preeclampsia** 5 (8.3) 0 (0) 0.057𝑏
Supplement intake** 48 (80.1) 32 (53.3) 0.002𝑏
Calcium intake** 27 (45) 15 (25) 0.022
Omega-3 intake** 8 (13.3) 1 (1.7) 0.032
Iron supplement intake** 41 (68.3) 22 (36.7) 0.001
Vitamin D supplementation** 12 (20) 5 (8.3) 0.067
Vitamin D status** 13 (21.7) 23 (38.3) 0.137𝑏
Sufficient** 4 (6.7) 3 (5)
Insufficient** 43 (71.7) 34 (56.7)
Deficiency** 13 (21.7) 23 (38.3)
yr: Year; wk: Week; BMI: Body mass index
Data presented as Mean ± SD; **Data presented as n (%)
𝑐p < 0.05 was considered to be significant;𝑎Independent t-test; 𝑏Chi-square test
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Table II. Comparison of serum levels of vitamin D, calcium, phosphorus, and PTH between the two groups
Parameters Preeclampsia Control P-value
Serum vitamin D levels (ng/ml) 6.12 (4.57-11.21) 15.18 (7.67-18.83) 0.007𝑎
Phosphorus (mg/dl) 4.08 ± 0.84 3.92 ± 0.71 0.204𝑏
Calcium (mg/dl) 9.37 ± 0.61 9.37 ± 0.39 0.942𝑏
Serum PTH (pg/ml) 23.05 (10.34-24.19) 24.56 (19.68-31.21) 0.956𝑎
Data presented as Mean ± SD
p < 0.05 was considered to be significant
𝑎Mann-Whitney U-Test; 𝑏Independent t-test
Table III. Comparison of daily dietary energy and nutrient intakes between cases and controls
Energy and nutrients Preeclampsia Control P-value 𝑎
Energy consumption from protein (%) 17.40 ± 1.71 12.24 ± 2.01 0.818
Energy consumption from
carbohydrate (%) 70.64 ± 5.04 70.37 ± 5.68 0.763
Energy consumption from fat (%) 11.93 ± 4.28 12.36 ± 4.77 0.871
Total protein (g) 142.93 ± 82.21 154.88 ±103.82 0.739
Total carbohydrate (g) 569.45 ± 302.51 653.47 ± 634.41 0.747
Total fat (g) 105.64 ± 84.21 121.25 ± 101.25 0.558
Energy (kcal) 3,692.36 ± 21.51 4,172.46 ± 32.84 0.688
Data presented as Mean ± SD
p < 0.05 was considered to be significant
𝑎Independent t-test
Table IV. Multivariate logistic regression analysis to determine the association between vitamin D deficiency and factors
related to preeclampsia development
Variables β Odds ratio (95% CI) P-value 𝑎
Age -0.013 0.98 (0.97-1.11) 0.07
Gestational age 0.067 1.06 (0.98-1.16) 0.11
Weight before pregnancy 0.029 1.02 (0.93-1.13) 0.55
Increased weight in first trimester 0.04 1.04 (0.94-1.15) 0.43
Vitamin D deficiency -0.306 0.27 (0.04-1.66) 0.15
Vitamin D insufficiency -0.053 0.55 (0.09-3.14) 0.51
p < 0.05 was considered to be significant
𝑎Wilcoxon-Mann-Whitney test
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Figure 1. Comparison of different variables between women with preeclampsia and control group. (A) Differences in vitamin D
levels; (B) Differences in Phosphorus levels; and (C) Differences in calcium levels.
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4. Discussion
In this study, we explored the differences in
the vitamin D status between the two groups of
pregnant women with preeclampsia and healthy
subjects. Our results suggest that vitamin D levels
in the preeclamptic pregnant subjects were sig-
nificantly lower than the healthy ones. However,
we did not find a correlation between vitamin
D deficiency and predisposing factors associated
with preeclampsia after adjusting for confound-
ing factors using multivariate regression analysis.
These observations are inconsistent with previous
surveys, showing vitamin D insufficiency to be
higher among preeclamptic pregnant women (17-
19). Many hypotheses have been suggested in
regards to the factors that could play a role in
the pathogenesis of preeclampsia. In addition,
vitamin D deficiency has been implicated as one
of the factors in the etiology of preeclampsia,
which stimulates systemic and vascular inflamma-
tion and results in inadequate placental devel-
opment (20, 21). However, establishing a clear
relationship between preeclampsia and vitamin D
deficiency among pregnant women is difficult due
to the complex nature of preeclampsia pathogene-
sis.
Low levels of serum vitamin D among
preeclamptic women were observed in several
studies. In a study done by Powe and colleagues
(22), pregnant women who had serum vitamin D <
15 ng/ml were at an increased risk of development
of preeclampsia. Similarly, Achkar and colleagues
(18) reported that the risk of preeclampsia in
women with vitamin D concentrations under 12
g/ml is higher. Although we observed that vitamin
D deficiency was significantly more prevalent
in our preeclamptic women, we could not find
a causal relationship between the low levels of
vitamin D concentration and increased risk of
developing preeclampsia. These discrepancies in
results from different surveys may be explained
by the role of unmeasured confounding factors.
Since most of the studies that were in favor of
the correlation between vitamin D deficiency
and preeclampsia, we did not assess genetic
factors or other lifestyle variables that could
potentially have an effect on serum vitamin D
levels.
Previous observational studies reported that the
risk of preeclampsia development may increase
in women with higher weight gain prior to preg-
nancy (23, 24). In a study done by Tsai and
colleagues, (25), it was reported that a higher
rate of preeclampsia occurrence was commonly
seen in pregnant women with excessive weight
gain during pregnancy, whereas obese women
with poor weight gain did not show similar
results. Similarly, the current study showed that
the BMI in the preeclamptic women was signif-
icantly higher compared to the control group.
In contrast to the previous studies, we did not
find a correlation between BMI and serum vita-
min D levels after adjustment for confounding
factors. Moreover, BMI was not considered as
an independently predictable factor of vitamin D
deficiency based on multivariable logistic regres-
sion. These findings could be explained by the
lower mean gestational age in the preeclamp-
tic women than in the control group. It has
been suggested that there is an inverse rela-
tionship between serum vitamin D level and
serum calcium and albumin level (26). However,
we did not identify any association between
these variables. This finding could be partly
explained by the fact that vitamin D level is
dependent on the exposure of sunlight and
dietary factors and thereby little or no change
in the level of vitamin D during pregnancy is
expected.
Over the years, considerable attention has been
directed to the role of malnutrition as a possible risk
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factor for developing preeclampsia (27). Lifestyle
factors including increased and reduced dietary
patterns of protein, fats or carbohydrates, and
sodium could play an important role in the etiology
of preeclampsia (28). Kazemian and colleagues (29)
reported that higher energy intakewas significantly
associated with the risk of preeclampsia. Simi-
larly, Clausen and colleagues (30) suggested that
women with high intake of polyunsaturated fatty
acids are associated with an increased likelihood
of preeclampsia development. On the contrary,
we did not find any difference in regards to any
micro/macronutrients intake among either of the
two groups. The main limitation of this study was
the small sample size of the study. It should be
noted that the other causes of vitamin D defi-
ciency such as alteration in vitamin D metabolism
during critical illness cannot be ruled out. Further
well-designed randomized control trials with large
sample size are warranted in order to elucidate
the exact therapeutic effect of vitamin D supple-
mentation in pregnant women with preeclamp-
sia.
5. Conclusion
Our study revealed that serum vitamin D level
is significantly lower in pregnant women diag-
nosed with preeclampsia compared to healthy
subjects. Although the exact role of vitamin D
in developing preeclampsia has not been fully
elucidated, it may have a clinical implication in
the management of these patients. However, no
correlation was observed between the vitamin
D status and the risk of preeclampsia devel-
opment. Thus, it is unclear whether vitamin D
supplementation in pregnant women may have a
protective effect against preeclampsia, and needs
to be examined in future well-designed clinical
trials.
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